Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • How smart spaces and real-time strategy transformed ASCO® 2025

    August 19, 2025 | Congress, Inizio, oncology 

    - PMLiVE

    Nick Bellomo, Director of Technology and Engagement, Inizio Medical

    ASCO® 2025 wasn’t just about oncology breakthroughs – it was also a showcase for how technology is redefining congress engagement. Supporting dozens of clients with hundreds of deliverables, Inizio had a front-row seat to innovations that are reshaping how healthcare professionals (HCPs) learn and interact.

    Highlights from the floor:

    • LED walls reimagined: Once static displays, LED walls are now interactive storytelling tools. From gesture-responsive MOAs to live trial dashboards, these experiences empowered HCPs to navigate content at their own pace, boosting engagement and driving more meaningful conversations.

    • Real-time in-booth analytics: Inizio piloted offline analytics that delivered live insights without internet dependency. This allowed brands to refine content mid-show, optimize staff alignment, and deliver more targeted education – all during the congress, not weeks later.

    Why it matters:
    These shifts mark a broader transformation: moving from passive storytelling to responsive engagement, and from delayed insights to real-time adaptability. For HCPs, this means richer, more relevant learning. For brands, it means smarter strategies and more impactful outcomes.

    At Inizio, the booth is no longer just a backdrop – it’s a catalyst for strategic engagement and patient-focused progress.

    Read the full article authored by Nick here. Discover more in the on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    A safe place to talk about Crohn’s

    Published in eyeforpharma April 2017 by Mariel Metcalfe

    Patient Assistance Programme Evaluation for Cardiovascular Conditions

    Our client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product.Read the case...

    What next for the treatment of Psoriasis in Europe?

    Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.

    20 questions: Round 1

    As it's our 20th year anniversary, we invited our employees to play 20 questions - this month "What's the biggest challenge you've overcome at Research Partnership?"Watch the video: https://www.researchpartnership.com/news/2017/03/20-questions-round-1/

    Brand tracking research

    A common challenge for brand tracking is ensuring the research programme stays relevant to the brand’s current environment. In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline...

    Pharma China Annual Forum 2017

    We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.

    Healthcare Market Research in the Gulf: 3 lessons I’ve learned

    A few key considerations for conducting healthcare market research in the Gulf

    Case study: Multiple Sclerosis new medical device research

    Our client wanted to find out how best to develop an implantable delivery device technology with add-on services in the Multiple Sclerosis market. We were tasked with finding out whether such a...

    Patient Centricity: Turning Rhetoric into Reality

    Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST

    Making sense of Nutraceuticals in China

    Published in eyeforpharma February 2017 by Marc Yates